The tariff classification of Desvenlafaxine Extended Release Tablets and Mesalamine Extended Release Capsules from India
Reasoning
The tariff classification of Desvenlafaxine Extended Release Tablets and Mesalamine Extended Release Capsules from India
Cite this ruling
CBP Ruling N316117 (3004909235): The tariff classification of Desvenlafaxine Extended Release Tablets and Mesalamine Extended Release Capsules from India
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300490
The tariff classification of Tamsulosin Capsules, Losartan Potassium Tablets and Losartan Potassium-Hydrochlorothiazide in dosage form, from India
The tariff classification of Tamsulosin Capsules, Losartan Potassium Tablets and Losartan Potassium-Hydrochlorothiazide in dosage form, from India
The tariff classification of Savella™ in dosage form and Milnacipran Hydrochloride (CAS-101152-94-7) in bulk form, from Ireland
The tariff classification of Diphenhydramine Hydrochloride (CAS-147-24-0) imported in measured dosage form in bulk drums, from India
The tariff classification of MittiHeal™ Natural Wound Care Powder in retail packaging from India